nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—Radial nerve palsy—Riluzole—amyotrophic lateral sclerosis	0.195	0.236	CcSEcCtD
Fludarabine—Wrist drop—Riluzole—amyotrophic lateral sclerosis	0.195	0.236	CcSEcCtD
Fludarabine—Alveolitis allergic—Riluzole—amyotrophic lateral sclerosis	0.0357	0.0433	CcSEcCtD
Fludarabine—RRM1—Synthesis and interconversion of nucleotide di- and triphosphates—GSR—amyotrophic lateral sclerosis	0.0183	0.144	CbGpPWpGaD
Fludarabine—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.0166	0.0202	CcSEcCtD
Fludarabine—RRM1—E2F transcription factor network—UXT—amyotrophic lateral sclerosis	0.0156	0.122	CbGpPWpGaD
Fludarabine—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0178	CcSEcCtD
Fludarabine—Respiratory distress—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0178	CcSEcCtD
Fludarabine—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0142	0.0172	CcSEcCtD
Fludarabine—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0166	CcSEcCtD
Fludarabine—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0164	CcSEcCtD
Fludarabine—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0153	CcSEcCtD
Fludarabine—Flavin adenine dinucleotide—DAO—amyotrophic lateral sclerosis	0.0126	0.372	CrCbGaD
Fludarabine—Adenosine triphosphate—ASNA1—amyotrophic lateral sclerosis	0.0117	0.346	CrCbGaD
Fludarabine—Flavin adenine dinucleotide—GSR—amyotrophic lateral sclerosis	0.00954	0.282	CrCbGaD
Fludarabine—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.0095	0.0115	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—UXT—amyotrophic lateral sclerosis	0.00878	0.069	CbGpPWpGaD
Fludarabine—Coma—Riluzole—amyotrophic lateral sclerosis	0.00853	0.0103	CcSEcCtD
Fludarabine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00786	0.00952	CcSEcCtD
Fludarabine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00757	0.00917	CcSEcCtD
Fludarabine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00747	0.00904	CcSEcCtD
Fludarabine—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00694	0.0084	CcSEcCtD
Fludarabine—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00677	0.0082	CcSEcCtD
Fludarabine—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.0063	0.00763	CcSEcCtD
Fludarabine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00625	0.00757	CcSEcCtD
Fludarabine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00585	0.00709	CcSEcCtD
Fludarabine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0057	0.00691	CcSEcCtD
Fludarabine—RRM1—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.00566	0.0445	CbGpPWpGaD
Fludarabine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00563	0.00682	CcSEcCtD
Fludarabine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00556	0.00673	CcSEcCtD
Fludarabine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00547	0.00663	CcSEcCtD
Fludarabine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00547	0.00663	CcSEcCtD
Fludarabine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00525	0.00636	CcSEcCtD
Fludarabine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00515	0.00623	CcSEcCtD
Fludarabine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00512	0.0062	CcSEcCtD
Fludarabine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00512	0.0062	CcSEcCtD
Fludarabine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00509	0.00616	CcSEcCtD
Fludarabine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00507	0.00614	CcSEcCtD
Fludarabine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00498	0.00603	CcSEcCtD
Fludarabine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00492	0.00596	CcSEcCtD
Fludarabine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0049	0.00593	CcSEcCtD
Fludarabine—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00471	0.0057	CcSEcCtD
Fludarabine—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00469	0.00567	CcSEcCtD
Fludarabine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00565	CcSEcCtD
Fludarabine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00563	CcSEcCtD
Fludarabine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00536	CcSEcCtD
Fludarabine—DCK—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.00436	0.0343	CbGpPWpGaD
Fludarabine—Chills—Riluzole—amyotrophic lateral sclerosis	0.0042	0.00509	CcSEcCtD
Fludarabine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00419	0.00507	CcSEcCtD
Fludarabine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00414	0.00501	CcSEcCtD
Fludarabine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00408	0.00494	CcSEcCtD
Fludarabine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00378	0.00458	CcSEcCtD
Fludarabine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00457	CcSEcCtD
Fludarabine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00375	0.00454	CcSEcCtD
Fludarabine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00368	0.00445	CcSEcCtD
Fludarabine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00442	CcSEcCtD
Fludarabine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00356	0.00431	CcSEcCtD
Fludarabine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00353	0.00428	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00353	0.0277	CbGpPWpGaD
Fludarabine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00421	CcSEcCtD
Fludarabine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00421	CcSEcCtD
Fludarabine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00343	0.00415	CcSEcCtD
Fludarabine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00406	CcSEcCtD
Fludarabine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00403	CcSEcCtD
Fludarabine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00403	CcSEcCtD
Fludarabine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00331	0.004	CcSEcCtD
Fludarabine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00326	0.00395	CcSEcCtD
Fludarabine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00326	0.00395	CcSEcCtD
Fludarabine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00322	0.0039	CcSEcCtD
Fludarabine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00384	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00367	CcSEcCtD
Fludarabine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00362	CcSEcCtD
Fludarabine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00359	CcSEcCtD
Fludarabine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00355	CcSEcCtD
Fludarabine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00289	0.0035	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00348	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00287	0.0226	CbGpPWpGaD
Fludarabine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00348	CcSEcCtD
Fludarabine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00345	CcSEcCtD
Fludarabine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00345	CcSEcCtD
Fludarabine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00332	CcSEcCtD
Fludarabine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00319	CcSEcCtD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00256	0.0201	CbGpPWpGaD
Fludarabine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00297	CcSEcCtD
Fludarabine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00289	CcSEcCtD
Fludarabine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00285	CcSEcCtD
Fludarabine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00276	CcSEcCtD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00218	0.0171	CbGpPWpGaD
Fludarabine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00256	CcSEcCtD
Fludarabine—Rash—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00254	CcSEcCtD
Fludarabine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00254	CcSEcCtD
Fludarabine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00209	0.00253	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00202	0.0159	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00199	0.0156	CbGpPWpGaD
Fludarabine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00239	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00198	0.0155	CbGpPWpGaD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00194	0.0153	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00192	0.0151	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00191	0.015	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.0018	0.0142	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00162	0.0128	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00162	0.0127	CbGpPWpGaD
Fludarabine—RRM1—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.00153	0.0121	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00151	0.0118	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00145	0.0114	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.0014	0.011	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00139	0.011	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.0013	0.0102	CbGpPWpGaD
Fludarabine—DCK—embryo—amyotrophic lateral sclerosis	0.00119	0.0912	CbGeAlD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00118	0.00924	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00112	0.00882	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00111	0.00875	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00111	0.0087	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00111	0.0087	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00108	0.00849	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00102	0.008	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00102	0.008	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00102	0.00799	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000986	0.00775	CbGpPWpGaD
Fludarabine—RRM1—medulla oblongata—amyotrophic lateral sclerosis	0.000982	0.075	CbGeAlD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00097	0.00763	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000931	0.00731	CbGpPWpGaD
Fludarabine—RRM1—spinal cord—amyotrophic lateral sclerosis	0.000876	0.0669	CbGeAlD
Fludarabine—POLA1—cerebellum—amyotrophic lateral sclerosis	0.000875	0.0668	CbGeAlD
Fludarabine—RRM1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000865	0.0068	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000825	0.00648	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000825	0.00648	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000813	0.00639	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000785	0.00617	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000784	0.00616	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000784	0.00616	CbGpPWpGaD
Fludarabine—DCK—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000783	0.00615	CbGpPWpGaD
Fludarabine—DCK—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000783	0.00615	CbGpPWpGaD
Fludarabine—DCK—medulla oblongata—amyotrophic lateral sclerosis	0.000763	0.0583	CbGeAlD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000763	0.006	CbGpPWpGaD
Fludarabine—RRM1—nervous system—amyotrophic lateral sclerosis	0.000738	0.0564	CbGeAlD
Fludarabine—RRM1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000736	0.00578	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000735	0.00578	CbGpPWpGaD
Fludarabine—DCK—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000716	0.00563	CbGpPWpGaD
Fludarabine—POLA1—brain—amyotrophic lateral sclerosis	0.000711	0.0543	CbGeAlD
Fludarabine—RRM1—central nervous system—amyotrophic lateral sclerosis	0.000711	0.0543	CbGeAlD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000706	0.00555	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000701	0.00551	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000701	0.00551	CbGpPWpGaD
Fludarabine—RRM1—cerebellum—amyotrophic lateral sclerosis	0.000695	0.053	CbGeAlD
Fludarabine—DCK—spinal cord—amyotrophic lateral sclerosis	0.00068	0.052	CbGeAlD
Fludarabine—POLA1—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000666	0.00524	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000666	0.00523	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000662	0.0052	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000633	0.00497	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000632	0.00497	CbGpPWpGaD
Fludarabine—DCK—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000626	0.00492	CbGpPWpGaD
Fludarabine—SLC29A1—nervous system—amyotrophic lateral sclerosis	0.0006	0.0458	CbGeAlD
Fludarabine—POLA1—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000596	0.00468	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000587	0.00461	CbGpPWpGaD
Fludarabine—SLC29A1—central nervous system—amyotrophic lateral sclerosis	0.000578	0.0441	CbGeAlD
Fludarabine—DCK—nervous system—amyotrophic lateral sclerosis	0.000573	0.0438	CbGeAlD
Fludarabine—DCK—Metabolism—DAO—amyotrophic lateral sclerosis	0.000566	0.00445	CbGpPWpGaD
Fludarabine—SLC29A1—cerebellum—amyotrophic lateral sclerosis	0.000565	0.0431	CbGeAlD
Fludarabine—RRM1—brain—amyotrophic lateral sclerosis	0.000564	0.0431	CbGeAlD
Fludarabine—RRM1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000557	0.00438	CbGpPWpGaD
Fludarabine—DCK—central nervous system—amyotrophic lateral sclerosis	0.000552	0.0421	CbGeAlD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000543	0.00427	CbGpPWpGaD
Fludarabine—DCK—cerebellum—amyotrophic lateral sclerosis	0.00054	0.0412	CbGeAlD
Fludarabine—RRM1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000514	0.00404	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000498	0.00392	CbGpPWpGaD
Fludarabine—SLC29A1—brain—amyotrophic lateral sclerosis	0.000459	0.035	CbGeAlD
Fludarabine—DCK—brain—amyotrophic lateral sclerosis	0.000438	0.0335	CbGeAlD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.00043	0.00338	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000429	0.00337	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000422	0.00332	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000398	0.00313	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSR—amyotrophic lateral sclerosis	0.000396	0.00311	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000376	0.00296	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000356	0.0028	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000331	0.0026	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000325	0.00256	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000281	0.00221	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000227	0.00178	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000212	0.00167	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000209	0.00164	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000175	0.00137	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000172	0.00135	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000161	0.00126	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOE—amyotrophic lateral sclerosis	0.000132	0.00104	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000118	0.000924	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TP53—amyotrophic lateral sclerosis	9.18e-05	0.000721	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.05e-05	0.000711	CbGpPWpGaD
